NasdaqGM - Nasdaq Real Time Price USD

Cronos Group Inc. (CRON)

2.8800 +0.3300 (+12.94%)
As of 2:35 PM EDT. Market Open.
Loading Chart for CRON
DELL
  • Previous Close 2.5500
  • Open 2.5300
  • Bid 2.8600 x 100
  • Ask 2.9400 x 500
  • Day's Range 2.4900 - 2.8800
  • 52 Week Range 1.6400 - 2.9900
  • Volume 6,598,338
  • Avg. Volume 3,064,275
  • Market Cap (intraday) 1.106B
  • Beta (5Y Monthly) 1.12
  • PE Ratio (TTM) --
  • EPS (TTM) -0.3000
  • Earnings Date May 9, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 2.61

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

www.thecronosgroup.com

356

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CRON

Performance Overview: CRON

Trailing total returns as of 4/30/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CRON
37.80%
S&P/TSX Composite index
4.10%

1-Year Return

CRON
54.01%
S&P/TSX Composite index
5.73%

3-Year Return

CRON
65.22%
S&P/TSX Composite index
13.31%

5-Year Return

CRON
83.07%
S&P/TSX Composite index
31.43%

Compare To: CRON

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CRON

Valuation Measures

Annual
As of 4/29/2024
  • Market Cap

    978.98M

  • Enterprise Value

    120.01M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    11.14

  • Price/Book (mrq)

    0.89

  • Enterprise Value/Revenue

    1.38

  • Enterprise Value/EBITDA

    -1.67

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -84.78%

  • Return on Assets (ttm)

    -4.24%

  • Return on Equity (ttm)

    -6.30%

  • Revenue (ttm)

    87.24M

  • Net Income Avi to Common (ttm)

    -69.85M

  • Diluted EPS (ttm)

    -0.3000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    861.53M

  • Total Debt/Equity (mrq)

    0.23%

  • Levered Free Cash Flow (ttm)

    -52.41M

Research Analysis: CRON

Analyst Price Targets

2.00 Low
2.61 Average
2.8800 Current
3.00
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: CRON

Fair Value

2.8800 Current
 

Dividend Score

0 Low
CRON
Sector Avg.
100 High
 

Hiring Score

0 Low
CRON
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
CRON
Sector Avg.
100 High
 

Research Reports: CRON

  • Analyst Report: Cronos Group Inc.

    Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S. the company has an option to acquire 10.5% of U.S. multistate operator PharmaCann upon easing of federal prohibition.

    Rating
    Price Target
     
  • Analyst Report: Cronos Group Inc.

    Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S. the company has an option to acquire 10.5% of U.S. multistate operator PharmaCann upon easing of federal prohibition.

    Rating
    Price Target
     
  • Analyst Report: Cronos Group Inc.

    Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S. the company has an option to acquire 10.5% of U.S. multistate operator PharmaCann upon easing of federal prohibition.

    Rating
    Price Target
     
  • Analyst Report: Cronos Group Inc.

    Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S. the company has an option to acquire 10.5% of U.S. multistate operator PharmaCann upon easing of federal prohibition.

    Rating
    Price Target
     

People Also Watch